Доцент ENVER ÖZKURT

Жалпы хирургия

Медипол Ажыбадем аймақтық ауруханасы
ENVER ÖZKURT

Туған жері

FATİH

Тілдер

İNGİLİZCE

Тәжірибе

2022 - 2026

İstanbul Florence Nightingale Hastanesi

2021 - 2022

İstanbul Özel Başarı Hastanesi

2017 - 2019

Harvard Tıp Fakültesi

2014 - 2017

İstanbul Üniversitesi İstanbul Tıp Fakültesi Genel Cerrahi C Servisi

2012 - 2014

Bitlis Devlet Hastanesi Genel Cerrahi Kliniği

2006

Bitlis Adilcevaz Devlet Hastanesi

Білім

2012

İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Genel Cerrahi

2006

Kocaeli Üniversitesi, Tıp Fakültesi

Жарияланымдар

1) The management of mesenteric vein thrombosis: a single institution's experience (Yanar F, Ağcaoğlu O,

Gök AF, Sarıcı IS, Ozçınar B, Aksakal N, Aksoy M, Ozkurt E, Kurtoğlu M.) (Ulus Travma Acil Cerrahi

Derg. 2013 May;19(3):223-8. doi:10.5505/tjtes.2013.47542) (PMID: 23720109)

3.5. BİLİMSEL YAYINLAR

7) Retroperitoneal Maligniteyi Taklit Eden Kronik Spontan Retroperitoneal Hematom. (İlhan M, Gok AFK,

Ozkurt E, Kose M, Ertekin C) (İç Hastalıkları Dergisi 2016 Cilt:23 Sayı:2; 119-122).

5) Lymphocytic Mastopathy: Mimicker of Breast Malignancy. (Yilmaz R, Yesil S, Bayramoglu Z, Ozkurt

E, Acunas G.) (Breast J. 2017 Mar;23(2):229-231).

2) Acute myocardial infarction associated with blood transfusion: Case report and literature review

(Velibey Y, Erbay A, Ozkurt E, Usta E, Akin F.) (Transfus Apher Sci. 2014 Jan 17. pii: S1473-

0502(14)00011-1. doi: 10.1016/j.transci.2014.01.009) (PMID: 24462652)

6) Favorable Outcome with Close Margins in Patients Undergoing Nipple/Skin Sparing Mastectomy with

Immediate Breast Reconstruction: 5-year Follow-up. (Özkurt E, Tükenmez M, Güven E, Çelet Özden B,

Öner G, Müslümanoğlu M, İğci A, Özmen V, Küçücük S, Cabioğlu N.) (Balkan Med J. 2017 Sep 29. doi:

10.4274/balkanmedj.2017.0029.).

4) Magnetic resonance imaging features of idiopathic granulomatous mastitis: is there any contribution of

diffusion-weighted imaging in the differential diagnosis? (Yilmaz R, Demir AA, Kaplan A, Sahin D,

Ozkurt E, Dursun M, Acunas G.) (Radiol Med. 2016 Nov;121(11):857-866)

8) Myofibroblastoma of the Breast: Ultrasonography, Mammography, and Magnetic Resonance Imaging

Features With Pathologic Correlation. (Yilmaz R, Akkavak G, Ozgur E, Onder S, Ozkurt E, Dursun M.)

(Ultrasound Q. 2018 Feb 7. doi: 10.1097/RUQ.0000000000000337.).

9) Surgical Highlights from the 40th San Antonio Breast Cancer Symposium: 5-9 December 2017, San

Antonio, Texas. (Özkurt E) (Eur J Breast Health. 2018 Apr 1;14(2):74-79. doi: 10.5152/ejbh.2018.0202.).

10) Favorable Long-Term Outcome in Male Breast Cancer. (Özkurt E, Tükenmez M, Yilmaz R, Cabioğlu

N, Müslümanoğlu M, Dinççağ A, İğci A, Özmen V) (Eur J Breast Health. 2018; 14: 180-185. doi:

10.5152/ejbh.2018.3946).

Page 15 of 34

11) Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients

Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy. (Cabioğlu N, Karanlık H,

Kangal D, Özkurt E, Öner G, Sezen F, Yılmaz R, Tükenmez M, Önder S, İğci A, Özmen V, Dinççağ A,

Engin G, Müslümanoğlu M) (Ann Surg Oncol. 2018 Jul 5. doi: 10.1245/s10434-018-6575-6.).

19) Özkurt E, Barbaros U, Aksakal N, Doğan S, Bozbora A. Single incision laparoscopic abdominal

surgeries: case series of 155 various procedures, an observational cohort study. Turk J Surg 2020; 36 (4):

353-358.

20) Özkurt E. Factors Affecting Patient Outcomes in Acute Appendicitis in Rural Areas: An Observational

Cohort Study. World J Surg. 2021 Apr 3. doi: 10.1007/s00268-021-06093-5. Epub 2021 Apr 3.

15) National trends of synchronous bilateral breast cancer incidence in the United States. (Sakai T, Özkurt

E, DeSantis S, Wong SM, Rosenbaum L, Zheng H, Golshan M) (Breast Cancer Res Treat.2019

Nov;178(1):161-167. doi: 10.1007/s10549-019-05363-0. Epub 2019 Jul 19.

13) The Effect of Isosulfan Blue Used for Sentinel Lymphnode Biopsy on Methemoglobine Level (Tolga

Totoz, Gulcin Ercan, Sitki N. Sinikoglu, Mustafa Tukenmez, Enver Ozkurt, Oguz Koc, Osman B.

Gulcicek, Yuksel Altinel, Hakan Yigitbas, and Atilla Celik) (Ely J Surg. 2018August:1(2):101.).

14) Our 20-Year Institutional Experience with Surgical Approach for Breast Hamartomas. (Türkyılmaz Z,

Aydın T, Yılmaz R, Önder S, Özkurt E, Tükenmez M, Müslümanoğlu M, Acunaş G, İğci A, Özmen V,

Dinççağ A, Cabioğlu N) (Eur J Breast Health. 2019 Jul 1;15(3):171-175. doi: 10.5152/ejbh.2019.4624).

16) Survival Outcomes for Patients with Clinical Complete Response After Neoadjuvant Chemotherapy: Is

Omitting Surgery an Option? (Özkurt E, Sakai T, Wong SM, Tükenmez M, Golshan M) (Ann Surg Oncol.

2019 Oct;26(10):3260-3268. doi: 10.1245/s10434-019-07534-1. Epub 2019 Jul 24).

17) ASO Author Reflections: De-escalation of Breast Cancer Surgery: A Leap Forward. (Özkurt E,

Golshan M) (Ann Surg Oncol. 2019 Dec;26(Suppl 3):711-712. doi: 10.1245/s10434-019-07759-0. Epub

2019 Aug 29).

18) Omission of Surgical Axillary Lymph Node Staging in Patients with Tubular Breast Cancer (Özkurt E,

Wong S, Rhei E, Golshan M, Brock J, Barbie TU). Ann Surg Oncol. 2020 Oct 19. doi: 10.1245/s10434-

020-09223-w. Epub 2020 Oct 19.

12) Intraoperative palpation of sentinel lymph nodes can accurately predict axilla in early breast cancer.

(Enver Ozkurt, Erkan Yardımcı, Mustafa Tükenmez, Yeliz Emine Ersoy, Ravza Yilmaz, Neslihan

Cabioğlu, Hasan Karanlık, Cemil Burak Kulle, Fatma Umit Malya, Semen Önder, Zuhal Gucin, Abdullah

İğci, Vahit Özmen, Ahmet Sait Dinççağ, Mahmut Müslümanoğlu) (Breast J. 2019 Jan;25(1):96-102. doi:

10.1111/tbj.13149. Epub 2018 Nov 12).

Page 16 of 34

26) Emiroglu S, Özkurt E, Cabıoglu N, Igci A, Saip P, Yazici H, Ozmen T, Ozmen V, Muslumanoglu M,

Tukenmez M. Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2

Germline Mutation? Breast Cancer (Dove Med Press). 2023 Feb 21;15:163-173. doi:

10.2147/BCTT.S395054. eCollection 2023.

29) Ünal Ç, Özmen T, İlgün AS, Ordu Ç, Özkurt E, Ak N, Alço G, Erdoğan İyigün Z, Kurt S, Duymaz T,

Öztürk MA, Elbüken Çelebi F, Yararbaş K, Soybir G, Aktepe F, Özmen V. MCM-2 Levels as a Potential

Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification. Breast

Cancer (Dove Med Press). 2023 Sep 1;15:659-669. doi: 10.2147/BCTT.S421535. eCollection 2023.

28) Cabioglu N, Trabulus DC, Emiroglu S, Ozkurt E, Yalcin N, Dinc N, Tukenmez M, Muslumanoglu M,

Igci A, Ozmen V, Dinccag AS, Guven YI. Ozone therapy as a novel complementary therapeutic approach

in refractory idiopathic granulomatous mastitis. Front Med (Lausanne). 2023 Jul 6;10:1174372. doi:

10.3389/fmed.2023.1174372. eCollection 2023.

27) Turkyilmaz Z, Sarisik E, Ozkurt E, Tukenmez M, Emiroglu S, Emiroglu B, Onder S, Yilmaz R,

Muslumanoglu M, Igci A, Ozmen V, Cabioglu N. Evaluation of Benign Breast Diseases With or Without

Atypical Epithelial Hyperplasia Accompanying Radial Scars. Eur J Breast Health. 2023 Apr 1;19(2):166-

171. doi: 10.4274/ejbh.galenos.2023.2022-10-4. eCollection 2023 Apr.

21) Cabıoğlu N, Karanlık H, Yıldırım N, Müslümanoğlu M, Çakmak Karadeniz G, Trabulus Can D,

Tükenmez M, Ersoy YE, Uras C, Zengel B, Emiroğlu S, Polat AK, Yeniay L, Özkurt E, Kara H, İbiş K,

Aydıner A, Özmen V, İğci A. Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant

chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTITURK

MF-18-02-study. Eur J Surg Oncol. 2021 Oct;47(10):2506-2514.

25) Özkurt E, Emiroğlu S, Cabioğlu N, Karanlık H, Önder S, Tükenmez M, İğci A, Özmen V,

Müslümanoğlu M. Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes.

Breast Care 2022 (DOI:10.1159/000525324). Epub 2022 Jun 2.

22) Özkurt E, İlhan M, Cücük Ö C, Tükenmez M, Cabioğlu N, Müslümanoğlu M E. Neuroendocrıne

carcınoma of the breast: 18 cases wıth long-term follow-up. Journal of Istanbul Faculty of Medicine.

2021;84(4):521-525. https://doi.org/10.26650/IUITFD.2021.830495

23) Cabioglu N, Cetin Aktas E, Emiroglu S, Tukenmez M, Ozkurt E, Muslumanoglu M, Igci A, Ozmen V,

Deniz G, Dinccag AS, Guven YI. Ozone therapy restores immune dysfunction in refractory idiopathic

granulomatous mastitis as a novel potential therapeutic approach. Cell Biol Int. 2022 Nov 15. doi:

10.1002/cbin.11953. Epub 2022 Nov 15.

24) Emiroglu S, Tukenmez M, Karakus S, Karanlik H, Onder S, Ozmen V, Cabioglu N, Ozkurt E, Yilmaz

R, Muslumanoglu M. Pure Mucinous Breast Carcinoma With a Favorable Tumor Biology and Clinical

Outcomes. Eur J Breast Health. 2022 Oct 1;18(4):353-359.

Page 17 of 34

37) Özkurt E, Ordu C, Özmen T, Ilgun AS, Soybir G, Celebi F, Koç E, Ak N, Alco G, Kurt S, Ağaçayak

F, Yavuz E, Tuzlalı S, Ozmen V. Vitamin D Supplementation During Neoadjuvant Chemotherapy for

Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial.

World J Surg. 2025 Jun;49(6):1396-1405. doi: 10.1002/wjs.12587. Epub 2025 Apr 14.

38) Cabıoğlu N, Ercan DO, Karataş İ, Eröz E, Toprak S, Emiroğlu S, Hüseynov E, Özkurt E,

Mollavelioğlu B, Tükenmez M, Müslümanoğlu M, İğci A, Özmen V. Changing practice patterns in axillary

management for patients with node-positive breast cancer towards increased use of sentinel lymph node

biopsy-alone after neoadjuvant chemotherapy: results of a survey (MF17-01) among Turkish surgeons.

Langenbecks Arch Surg. 2025 Jun 16;410(1):196. doi: 10.1007/s00423-025-03767-9.

35) Erdoğan İyigün Z, Ozmen T, İlgün S, Nakipoğlu C, Özkurt E, Çelebi F, Ünal Ç, Öztürk A, Alço G,

Ordu Ç, Soybir G. Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema

Diagnosed in the Preoperative Period via Bioimpedance. Eur J Breast Health. 2025 Jan 1;21(1):40-45. doi:

10.4274/ejbh.galenos.2024.2024-9-5.

36) Cabioglu N, Koçer HB, Karanlik H, Gülçelik MA, Igci A, Müslümanoglu M, Uras C, Mantoglu B,

Trabulus DC, Akgül G, Tükenmez M, Senol K, Özkurt E, et al. De-Escalation of Nodal Surgery in

Clinically Node-Positive Breast Cancer. JAMA Surg. 2025 Mar 1;160(3):257-266. doi:

10.1001/jamasurg.2024.5913.

33) Muslumanoglu M, Cabioglu N, Igci A, Karanlık H, Kocer HB, Senol K, Mantoglu B, Tukenmez M,

Çakmak GK, Ozkurt E, et al. Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies:

ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with

a good response to neoadjuvant chemotherapy as long as radiotherapy is provided. Cancer. 2024 Oct 30.

doi: 10.1002/cncr.35610.

34) Cabioglu N, Karanlik H, Igci A, Muslumanoglu M, Gulcelik MA, Uras C, Kocer HB, Trabulus DC,

Ozkurt E, et al. Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-

02/18-03. Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16472-6.

30) Ünal Ç, Ordu Ç, Özmen T, İlgun AS, Çelebi F, Baysal B, Özkurt E, Duymaz T, Erdoğan İyigün Z,

Kurt S, Öztürk MA, Pilancı KN, Alço G, Yararbaş K, Kayan Tapan T, Güven DC, Soybir G, Özmen V.

Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in

Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study. Curr

Oncol. 2023 Oct 19;30(10):9217-9229. doi: 10.3390/curroncol30100666.

32) Kayan Tapan T, Çelebi F, Yaghouti K, Ağaçayak F, İlgün S, Soybir G, Alço G, Ak N, Ordu Ç, Özkurt

E, Ünal Ç, Kurt S, Öztürk A, İyigün Z, Duymaz T, Özmen V. The Relationship of Pathological Response

and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant

Chemotherapy. Eur J Breast Health. 2024 Apr 1;20(2):117-121. doi: 10.4274/ejbh.galenos.2024.2023-12-5.

eCollection 2024 Apr.

31) Kurt S, İlgün AS, Özkurt E, Soybir G, Alço G, Ünal Ç, Çelebi FE, Duymaz T, Tapan TK, Ak N, Ordu

Ç, Özmen V. Outcomes of reconstructive techniques in breast cancer using BCCT. core software. World J

Surg Oncol. 2024 Mar 23;22(1):82. doi: 10.1186/s12957-024-03343-3.

Page 18 of 34

39) Cabıoğlu N, Karanlık H, Özmen V, Tükenmez M, İğci A, Aytin YE, Köksal H, Mutlu H, Bademler S,

Uras C, Dülgeroğlu O, Özkurt E, et al. Omitting Axillary Dissection in Triple-Negative and HER2-

Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURKOTHELLO

Study. Clin Breast Cancer. 2025 Jul;25(5):455-463. doi: 10.1016/j.clbc.2025.02.002. Epub

2025 Feb 8.

40) Özkurt E, Ordu Ç, Koç E, Gokmen E, Ozdogan M, Guler N, Uras C, Öz B, Demircan O, Isikdogan A,

Saip P, Ozmen V. Survival of the Patients With Breast Cancer Who Underwent Oncotype DX Recurrence

Score Testing: Long-Term Survival Update of a Prospective Multicenter Study in Türkiye According to

Different Cut-Offs. World J Surg. 2025 Sep;49(9):2303-2313. doi: 10.1002/wjs.70025. Epub 2025 Aug 1.

41) Cabıoğlu N, Karanlık H, Iğci A, Müslümanoğlu M, Gürsoy OM, Tükenmez M, Polat NC, Özkurt E,

Emiroğlu S, Yıldırım N, Ilgün AS, Önder S, Yılmaz R, Dursun M, Simşek DH, Saip P, Aydıner A, Bayram

A, Mollavelioğlu B, Ibiş K, Küçücük S, Özmen V. Factors Predicting Additional Residual Nodal Disease

With a Metastatic Sentinel Node Biopsy or Targeted Axillary Dissection After Neoadjuvant Chemotherapy.

J Breast Cancer. 2025 Oct;28(5):322-332. doi: 10.4048/jbc.2025.0052. Epub 2025 Aug 5.

42) Karadeniz Cakmak G, Tali U, Balbaloglu H, Tasdoven I, Ozkurt E, Karanlik H, et al. Causes of

diagnostic and treatment delays in locally advanced breast cancer: a nationwide multicenter survey and

electronic health records analysis in Turkiye. Eur J Public Health. 2025 Dec 1;35(6):1271-1280. doi:

10.1093/eurpub/ckaf108.

43) Cabıoğlu N, Türkyılmaz Z, Özkurt E, İğci A, Müslümanoğlu M, Kapkaç M, Yeniay L, et al. Poor

Prognostic Clinicopathological Features of Young Women with Breast Cancer in the MF18-04 Turkish

National Breast Cancer Registry Study. Asian Pac J Cancer Prev. 2025 Dec 1;26(12):4407-4417. doi:

10.31557/APJCP.2025.26.12.4407.

44) Vusal Aliyev, Zeliha Turkyılmaz, Enver Özkurt, Mehmet Durmus Kurt, Mustafa Tukenmez, Selman

Emiroglu, Sibel Ozkan Gurdal, Beyza Ozcinar, Fatih Levent Balci, Omer Bender, Mahmut Muslumanoglu

and Neslihan Cabioglu. Ductoscopy Facilitates Surgical Decision-Making in Management of Patients with

Pathological Nipple Discharge. Diagnostics 2026, 16(6), 856; DOI: 10.3390/diagnostics16060856.